Nazzareno Dimasi

A Biparatopic HER2-Targeting Antibody-Drug Conjugate Induces Tumor Regression in Primary Models Refractory to or Ineligible for HER2-Targeted Therapy

John Y. Li, Samuel R. Perry, Vanessa Muniz‐Medina et al. · Cancer Cell · 2016 · 375 citations · Full text

Drug Targeting, Her2-targeted Therapy, Medicine +10

A multifunctional bispecific antibody protects against <i>Pseudomonas aeruginosa</i>

Antonio DiGiandomenico, Ashley Keller, Cuihua Gao et al. · Science Translational Medicine · 2014 · 272 citations

Crystal Structure of a Superantigen Bound to the High-Affinity, Zinc-Dependent Site on MHC Class II

Yili Li, Hongmin Li, Nazzareno Dimasi et al. · Immunity · 2001 · 135 citations · Full text

Crystal Structure, Physics, Natural Sciences +6

Variable MHC class I engagement by Ly49 natural killer cell receptors demonstrated by the crystal structure of Ly49C bound to H-2Kb

Julie Dam, Rongjin Guan, Kannan Natarajan et al. · Nature Immunology · 2003 · 133 citations

Crystal Structure, Ly49c Bound, Variable Mhc Class +7

Antibody–Drug Conjugates Bearing Pyrrolobenzodiazepine or Tubulysin Payloads Are Immunomodulatory and Synergize with Multiple Immunotherapies

Jonathan Rios‐Doria, Jay Harper, Raymond Rothstein et al. · Cancer Research · 2017 · 124 citations